Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis

Life Sciences

Volumn 123, Issue , 2015, Pages 51-60

  Passos, E ^a,b   Pereira, C D ^a   Goncalves I O ^b   Rocha Rodrigues, S ^b   Silva, N ^c   Guimaraes J T ^a,c   Neves, D ^a   Ascensao A ^b   Magalhaes J ^b   Martins, M J ^a  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c HOSPITAL DE SÃO JOÃO   (Portugal)

Author keywords

Endurance training; Glucocorticoid signaling; High fat diet; Inflammation; Insulin signaling; Non alcoholic steatohepatitis; Voluntary physical activity

Indexed keywords

GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INSULIN; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; OXIDOREDUCTASE; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; PRIMER DNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSESSMENT OF HUMANS; COMPARATIVE STUDY; CONTROLLED STUDY; ENDURANCE TRAINING; EXERCISE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY INDEX; LIPID DIET; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; VOLUNTARY PHYSICAL ACTIVITY; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; COMPLICATION; ENDURANCE; GENETICS; INSULIN RESISTANCE; METABOLISM; MOTOR ACTIVITY; NON-ALCOHOLIC FATTY LIVER DISEASE; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; BLOTTING, WESTERN; DIET, HIGH-FAT; DNA PRIMERS; GLUCOCORTICOIDS; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; MALE; MOTOR ACTIVITY; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84921665807     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.12.013     Document Type: Article

References (69)

1. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
2. D. Schuppan, and J.M. Schattenberg Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches J. Gastroenterol. Hepatol. 28 Suppl. 1 2013 68 76
3. A. Ahmed, E. Rabbitt, and T. Brady A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease PLoS One 7 2012 e29531
4. L. Yang, Y.S. Roh, and J. Song Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice Hepatology 59 2014 483 495
5. J. Hirosumi, G. Tuncman, and L. Chang A central role for JNK in obesity and insulin resistance Nature 420 2002 333 336
6. D. Cai, M. Yuan, and D.F. Frantz Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB Nat. Med. 11 2005 183 190
7. C.D. Pereira, I. Azevedo, R. Monteiro, and M.J. Martins 11beta-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus Diabetes Obes. Metab. 14 2012 869 881
8. H. Yadav, C. Quijano, and A.K. Kamaraju Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling Cell Metab. 14 2011 67 79
9. P. Gual, Y. Le Marchand-Brustel, and J.F. Tanti Positive and negative regulation of insulin signaling through IRS-1 phosphorylation Biochimie 87 2005 99 109
10. J.F. Tanti, F. Ceppo, J. Jager, and F. Berthou Implication of inflammatory signaling pathways in obesity-induced insulin resistance Front. Endocrinol. (Lausanne) 3 2012 181
11. J.K. Kim Endothelial nuclear factor kappaB in obesity and aging: is endothelial nuclear factor kappaB a master regulator of inflammation and insulin resistance? Circulation 125 2012 1081 1083
12. R. Meshkani, and K. Adeli Hepatic insulin resistance, metabolic syndrome and cardiovascular disease Clin. Biochem. 42 2009 1331 1346
13. S.O. Sanderson, and T.C. Smyrk The use of protein tyrosine phosphatase 1B and insulin receptor immunostains to differentiate nonalcoholic from alcoholic steatohepatitis in liver biopsy specimens Am. J. Clin. Pathol. 123 2005 503 509
14. J.M. Zabolotny, Y.B. Kim, and L.A. Welsh Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo J. Biol. Chem. 283 2008 14230 14241
15. M. Elchebly, P. Payette, and E. Michaliszyn Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene Science 283 1999 1544 1548
16. F.G. Haj, J.M. Zabolotny, Y.B. Kim, B.B. Kahn, and B.G. Neel Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B -/- mice J. Biol. Chem. 280 2005 15038 15046
17. K.K. Bence Hepatic PTP1B deficiency: the promise of a treatment for metabolic syndrome? J. Clin. Metab. Diabetes 1 2010 27 33
18. T.O. Johnson, J. Ermolieff, and M.R. Jirousek Protein tyrosine phosphatase 1B inhibitors for diabetes Nat. Rev. Drug Discov. 1 2002 696 709
19. R. Amat, G. Solanes, M. Giralt, and F. Villarroya SIRT1 is involved in glucocorticoid-mediated control of uncoupling protein-3 gene transcription J. Biol. Chem. 282 2007 34066 34076
20. A.J. Rose, and S. Herzig Metabolic control through glucocorticoid hormones: an update Mol. Cell. Endocrinol. 380 2013 65 78
21. A. Vegiopoulos, and S. Herzig Glucocorticoids, metabolism and metabolic diseases Mol. Cell. Endocrinol. 275 2007 43 61
22. M.J. Saad, F. Folli, J.A. Kahn, and C.R. Kahn Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats J. Clin. Invest. 92 1993 2065 2072
23. A. Cayon, J. Crespo, M. Mayorga, A. Guerra, and F. Pons-Romero Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis Liver Int. 26 2006 1065 1071
24. L. Lionetti, M.P. Mollica, and R. Sica Differential effects of high-fish oil and high-lard diets on cells and cytokines involved in the inflammatory process in rat insulin-sensitive tissues Int. J. Mol. Sci. 15 2014 3040 3063
25. M. Uno, S. Kurita, and H. Misu Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis Hepatology 48 2008 109 118
26. B.K. Pedersen, and M.A. Febbraio Muscles, exercise and obesity: skeletal muscle as a secretory organ Nat. Rev. Endocrinol. 2012
27. G. Bhat, C.S. Baba, A. Pandey, N. Kumari, and G. Choudhuri Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease World J. Hepatol. 4 2012 209 217
28. G. da Luz, M.J. Frederico, and S. da Silva Endurance exercise training ameliorates insulin resistance and reticulum stress in adipose and hepatic tissue in obese rats Eur. J. Appl. Physiol. 111 2011 2015 2023
29. S. Oh, K. Tanaka, and T. Tsujimoto Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease Metab. Syndr. Relat. Disord. 2014
30. I.O. Goncalves, E. Passos, and S. Rocha-Rodrigues Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders Clin. Nutr. 2014
31. C.S. Lieber, M.A. Leo, and K.M. Mak Model of nonalcoholic steatohepatitis Am. J. Clin. Nutr. 79 2004 502 509
32. J. Cacho, J. Sevillano, J. de Castro, E. Herrera, and M.P. Ramos Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats Am. J. Physiol. Endocrinol. Metab. 295 2008 E1269 E1276
33. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
34. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
35. M. Locke, E.G. Noble, and B.G. Atkinson Exercising mammals synthesize stress proteins Am. J. Physiol. 258 1990 C723 C729
36. N. Kawanishi, H. Yano, and T. Mizokami Exercise training attenuates hepatic inflammation, fibrosis and macrophage infiltration during diet induced-obesity in mice Brain Behav. Immun. 26 2012 931 941
37. K.D. Kistler, E.M. Brunt, and J.M. Clark Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease Am. J. Gastroenterol. 106 2011 460 468 quiz 469
38. D.E. Kleiner, E.M. Brunt, and M. Van Natta Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
39. S. Choi, Y. Choi, S. Kim, J. Jang, and T. Park Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice Food Chem. 141 2013 3627 3635
40. K.D. Copps, and M.F. White Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 Diabetologia 55 2012 2565 2582
41. S. Guo Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms J. Endocrinol. 220 2014 T1 T23
42. G. Solinas, and M. Karin JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction FASEB J. 24 2010 2596 2611
43. V. Aguirre, T. Uchida, L. Yenush, R. Davis, and M.F. White The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J. Biol. Chem. 275 2000 9047 9054
44. S. Boura-Halfon, and Y. Zick Phosphorylation of IRS proteins, insulin action, and insulin resistance Am. J. Physiol. Endocrinol. Metab. 296 2009 E581 E591
45. J.F. Tanti, and J. Jager Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation Curr. Opin. Pharmacol. 9 2009 753 762
46. H.Y. Liu, T. Hong, and G.B. Wen Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance Am. J. Physiol. Endocrinol. Metab. 297 2009 E898 E906
47. Y. Zheng, W. Zhang, and E. Pendleton Improved insulin sensitivity by calorie restriction is associated with reduction of ERK and p70S6K activities in the liver of obese Zucker rats J. Endocrinol. 203 2009 337 347
48. E. Hui, A. Xu, H. Bo Yang, and K.S. Lam Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: role of adipokines J. Diabetes Investig. 4 2013 413 425
49. C.G. Schnackenberg, M.H. Costell, and D.J. Krosky Chronic inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome Biomed. Res. Int. 2013 2013 427640
50. R.S. Hardy, K. Raza, and M.S. Cooper Endogenous glucocorticoids in inflammation: contributions of systemic and local responses Swiss Med. Wkly. 142 2012 w13650
51. P. Alberts, C. Nilsson, and G. Selen Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains Endocrinology 144 2003 4755 4762
52. N.M. Morton, M.C. Holmes, and C. Fievet Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice J. Biol. Chem. 276 2001 41293 41300
53. A. Joharapurkar, N. Dhanesha, G. Shah, R. Kharul, and M. Jain 11beta-Hydroxysteroid dehydrogenase type 1: potential therapeutic target for metabolic syndrome Pharmacol. Rep. 64 2012 1055 1065
54. S.A. Morgan, M. Sherlock, and L.L. Gathercole 11beta-Hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle Diabetes 58 2009 2506 2515
55. L. Wang, J. Liu, and A. Zhang BVT.2733, a selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice PLoS One 7 2012 e40056
56. A.E. Coutinho, J.E. Campbell, S. Fediuc, and M.C. Riddell Effect of voluntary exercise on peripheral tissue glucocorticoid receptor content and the expression and activity of 11beta-HSD1 in the Syrian hamster J. Appl. Physiol. 100 2006 1483 1488
57. M.E. Kotas, M.C. Gorecki, and M.P. Gillum Sirtuin-1 is a nutrient-dependent modulator of inflammation Adipocytes 2 2013 113 118
58. D. Wei, R. Tao, Y. Zhang, M.F. White, and X.C. Dong Feedback regulation of hepatic gluconeogenesis through modulation of SHP/Nr0b2 gene expression by Sirt1 and FoxO1 Am. J. Physiol. Endocrinol. Metab. 300 2011 E312 E320
59. F. Xu, Z. Gao, and J. Zhang Lack of SIRT1 (mammalian sirtuin 1) activity leads to liver steatosis in the SIRT1 +/- mice: a role of lipid mobilization and inflammation Endocrinology 151 2010 2504 2514
60. F. Yeung, J.E. Hoberg, and C.S. Ramsey Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase EMBO J. 23 2004 2369 2380
61. C. Sun, F. Zhang, and X. Ge SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B Cell Metab. 6 2007 307 319
62. G. Tarantino, and A. Caputi JNKs, insulin resistance and inflammation: a possible link between NAFLD and coronary artery disease World J. Gastroenterol. 17 2011 3785 3794
63. G. Tarantino, F. Scopacasa, and A. Colao Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease World J. Gastroenterol. 17 2011 5280 5288
64. G. Tarantino, A. Colao, and D. Capone Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease J. Biol. Regul. Homeost. Agents 25 2011 47 56
65. P.C. Heinrich, I. Behrmann, and S. Haan Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem. J. 374 2003 1 20
66. A.P. Costa-Pereira Regulation of IL-6-type cytokine responses by MAPKs Biochem. Soc. Trans. 42 2014 59 62
67. G. Florholmen, G.H. Thoresen, and A.C. Rustan Leukaemia inhibitory factor stimulates glucose transport in isolated cardiomyocytes and induces insulin resistance after chronic exposure Diabetologia 49 2006 724 731
68. C. Finelli, and G. Tarantino What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J. Gastroenterol. 19 2013 802 812
69. G.C. Farrell Signalling links in the liver: knitting SOCS with fat and inflammation J. Hepatol. 43 2005 193 196